Best Peptides for Longevity Research 2026: Epithalon, GHK-Cu, MOTS-c & More — Buyer's Guide

# Best Peptides for Longevity Research 2026: Epithalon, GHK-Cu, MOTS-c & More — Buyer's Guide

> For Research Purposes Only. The compounds discussed in this guide are research peptides intended for laboratory and scientific investigation only. They are not FDA-approved for human use, are not intended for self-administration, and should not be interpreted as medical advice. Consult a licensed healthcare professional for any health-related decisions.

The longevity research space has never been more active. From academic geroscience labs to translational biotech companies, the hunt for compounds capable of slowing biological aging or extending healthspan is producing a wave of scientific interest in peptide biology. Among the compounds attracting the most rigorous attention in 2026 are a set of peptides with mechanisms spanning telomere biology, mitochondrial function, thymic restoration, cellular stress response, and systemic anti-inflammatory signaling.

This buyer's guide covers the 8 most researched longevity-focused peptides currently available for scientific study — examining what each does, what the peer-reviewed evidence shows, how prices compare across verified suppliers on Peptides.SO, and how researchers are combining them into synergistic protocols.

---

How to Read This Guide

Each compound section includes:

• •Primary mechanism — how it works at the molecular and cellular level
• •Research status — where it sits on the evidence ladder from cell culture to human trials
• •Key studies — the most significant published papers
• •Platform pricing — current price range from Peptides.SO verified suppliers
• •Stack suggestions — complementary compounds studied alongside it

A comparison table at the end summarizes all 8 compounds.

---

1. Epithalon (Epitalon)

Background

Epithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It was developed by Prof. Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology as a synthetic analog of the naturally occurring pineal peptide preparation Epithalamin. It represents one of the most extensively studied bioregulatory peptides in the longevity field, with research spanning over four decades.

Mechanism of Action

Epithalon's headline mechanism is the activation of telomerase — the enzyme that adds telomeric repeats (TTAGGG in humans) to chromosome ends, counteracting the progressive telomere shortening (PMID: 15455129). that occurs with each cell division. Telomere attrition is one of the hallmark mechanisms of replicative cellular aging; as telomeres shorten below a critical threshold, cells enter senescence or apoptosis.

Epithalon research also encompasses:

• •Pineal modulation — stimulation of melatonin synthesis and restoration of circadian rhythmicity in aged subjects
• •Antioxidant effects — reduction of lipid peroxidation and reactive oxygen species in tissue models
• •Oncostatic properties — inhibition of tumor growth in multiple animal cancer models
• •Neuroendocrine normalization — partial restoration of age-related hormonal imbalances including cortisol and DHEA

Key Research

A landmark in vitro study by Khavinson et al. demonstrated that Epithalon treatment induced telomerase activity and promoted telomere elongation in human somatic cells — a finding that remains the foundational basis for Epithalon's longevity applications. Subsequent animal research showed that Epithalon-treated rodents exhibited up to 11% increases in maximum lifespan (PMID: 25826983). alongside preserved immune function and reduced cancer incidence compared to controls.

Anisimov and colleagues documented in multiple publications that chronic Epithalon administration in aging rats reduced the incidence of spontaneous mammary tumors and preserved retinal function, while simultaneously improving melatonin secretion patterns. The combination of cancer prevention and circadian normalization in these animal studies has made Epithalon one of the most widely discussed longevity compounds in the bioregulator literature.

A key feature of the evidence base is its longevity: Epithalon research began in the 1980s and has continued uninterrupted, providing an unusually long experimental track record for a non-pharmaceutical research compound.

Research Status

Preclinical + Russian Clinical Data. Most published research is preclinical. Russian clinical investigations over 30+ years have established preliminary safety data in human subjects, but large-scale randomized controlled trials using Western GCP standards are lacking. Epithalon remains firmly in the research compound category.

Platform Pricing

Epithalon is widely available on Peptides.SO from multiple verified suppliers. Typical pricing ranges from $30 to $150 for a 10mg vial, with pricing reflecting purity certification, source country, and supplier tier. Lyophilized powder is the most stable and commonly available form; nasal spray preparations are also offered by some suppliers.

Compare prices: /peptide/epithalon

Best Stacked With

Epithalon + GHK-Cu is the most classically researched longevity pairing, targeting complementary mechanisms of telomere biology and gene expression regeneration. Epithalon + DSIP addresses both longevity and sleep architecture normalization. Some researchers include Thymalin in Epithalon-based protocols to add thymic-immune restoration to the combination.

---

2. GHK-Cu (Copper Peptide)

Background

GHK-Cu (Glycine-Histidine-Lysine copper complex) is a naturally occurring tripeptide found in human plasma, urine, and saliva. It was originally isolated and characterized by Loren Pickart, PhD in 1973. While initially studied in the context of wound healing and skin regeneration, GHK-Cu's mechanistic breadth — particularly its gene expression modulation — has made it a compelling longevity research candidate.

Mechanism of Action

GHK-Cu complexes with copper ions to activate a wide range of biological pathways. Comprehensive gene array studies have revealed that GHK-Cu modulates the expression of over 4,000 human genes (PMID: 26236730). — approximately 30% of human protein-coding genes — with the predominant direction being restoration of aged gene expression patterns toward younger, more physiological states.

Key mechanisms include:

• •Collagen and elastin synthesis — upregulation of decorin, collagen types I and III, and elastin in fibroblasts
• •Autophagy promotion — activation of autophagy-related genes including Beclin-1 and ATG7, supporting cellular "self-cleaning"
• •Antioxidant gene upregulation — activation of superoxide dismutase (SOD), catalase, and other antioxidant enzymes
• •Anti-inflammatory gene modulation — suppression of NF-κB, TGF-β1, and pro-inflammatory cytokine genes
• •Stem cell activation — promotion of tissue-resident mesenchymal stem cell proliferation
• •BDNF and NGF expression — neurotrophin upregulation with implications for neurological aging

Key Research

Pickart and Margolina's review synthesized decades of GHK-Cu evidence, documenting its capacity to reverse many age-associated gene expression changes while simultaneously promoting tissue regeneration. This paper established GHK-Cu as more than a wound-healing peptide — it is a broad-spectrum biological signaling molecule.

Subsequent computational analyses have identified GHK-Cu's gene regulation pattern as overlapping substantially with known anti-aging gene signatures, including those associated with caloric restriction and mTOR inhibition. These bioinformatic findings suggest that GHK-Cu activates many of the same longevity pathways as better-known interventions through independent mechanisms.

Research in skin biology has provided some of the strongest translational evidence: double-blind clinical studies in dermatology have demonstrated improvements in skin thickness, firmness, fine line reduction, and wound healing rate in GHK-Cu-treated subjects compared to controls — establishing human proof-of-concept for at least some of its regenerative effects.

Research Status

Highest Evidence Base Among Longevity Peptides. GHK-Cu has the largest published body of research of any peptide in this category — thousands of peer-reviewed papers spanning cell biology, animal studies, and human dermatology trials. While systemic longevity applications remain preclinical, the mechanistic evidence is compelling and the safety profile is well-established.

Platform Pricing

GHK-Cu is among the most widely available research peptides, with pricing from $25 to $150 for a 50mg vial depending on purity grade and supplier. Cosmetic-grade GHK-Cu solutions are widely available but are different from research-grade lyophilized powder; purity documentation should be verified before use in systematic research.

Browse available GHK-Cu products: /peptide/ghk-cu

Best Stacked With

GHK-Cu + Epithalon is the premier longevity combination, addressing both telomere biology and gene expression rejuvenation. GHK-Cu + BPC-157 is studied for broad tissue regeneration. GHK-Cu + KPV combines two anti-inflammatory peptides for inflammation-centered aging research.

---

3. MOTS-c

Background

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded entirely within the mitochondrial genome. Its discovery by Chang-han David Lee and colleagues at the University of Southern California in 2015 established a new class of biological regulators: mitochondria-derived peptides (MDPs) — short sequences encoded in mitochondrial DNA that function as systemic hormones.

The discovery had major implications for aging biology: MOTS-c levels in circulation decline with age, and higher MOTS-c levels correlate with better metabolic health, lower inflammation, and enhanced physical function in older adults.

Mechanism of Action

MOTS-c functions primarily through activation of AMPK (PMID: 25738459). (AMP-activated protein kinase), the cellular energy sensor that coordinates glucose uptake, fat oxidation, mitochondrial biogenesis, and autophagy. Its key studied effects include:

• •Insulin sensitization — improved glucose uptake in skeletal muscle through AMPK-dependent GLUT4 translocation
• •Exercise mimicry — in rodent studies, MOTS-c administration improved endurance capacity and muscle function independently of actual exercise
• •Mitochondrial biogenesis — upregulation of PGC-1α, the master regulator of mitochondrial number and function
• •Nuclear translocation — during cellular stress, MOTS-c translocates to the nucleus where it modifies gene transcription, effectively "reporting" mitochondrial status to the genome
• •Folate cycle modulation — interference with the one-carbon metabolic cycle, affecting methionine metabolism and DNA methylation

A critical longevity connection: AMPK activation mimics caloric restriction at the cellular level, suggesting MOTS-c may partially replicate the lifespan-extending effects of caloric restriction through a druggable mechanism.

Key Research

The landmark discovery paper (Lee C et al., Cell Metabolism,, 2015) established MOTS-c as a systemic hormonal signal derived from mitochondria, demonstrated its AMPK activation mechanism, and showed that it prevented diet-induced obesity and insulin resistance in mice. This study established the entire field of MDP research.

Follow-up work from multiple groups documented that:

• •MOTS-c circulating levels decline significantly with age in both humans and mice
• •MOTS-c administration in old mice restores exercise tolerance and muscle function toward youthful levels
• •MOTS-c crosses the blood-brain barrier and exerts neuroprotective effects in neurodegeneration models
• •Higher MOTS-c in human populations correlates with exceptional longevity (studies in centenarian cohorts)
• •MOTS-c reduces age-related inflammatory markers through NF-κB suppression

A 2021 study from Kim et al. specifically demonstrated MOTS-c's capacity to restore muscle stem cell (satellite cell) function in aged mice — a direct mechanistic connection to the prevention of age-related sarcopenia.

Research Status

Strong Academic Preclinical Evidence. MOTS-c research is newer than Epithalon or GHK-Cu but comes from top-tier academic institutions and high-impact journals. Clinical trials in humans are in early stages. Its discovery from actual mitochondrial biology gives it strong mechanistic credibility.

Platform Pricing

MOTS-c is a specialty peptide with limited but growing availability. Typical pricing is $99–$250 for a 5–10mg vial. Fewer suppliers currently carry it compared to older compounds; quality verification is particularly important.

Compare options: /peptide/mots-c

Best Stacked With

MOTS-c + Humanin is the most studied MDP combination, with potentially complementary roles in mitochondrial metabolism (MOTS-c) and cellular cytoprotection (Humanin). MOTS-c + SS-31 addresses both metabolic mitochondrial signaling and structural mitochondrial integrity in a comprehensive mitochondrial health protocol.

---

4. Humanin

Background

Humanin (HN) is a 21-amino acid mitochondria-derived peptide encoded in the 16S ribosomal RNA region of mitochondrial DNA. It was discovered in 2001 by Yasuji Hashimoto and colleagues at the Tokyo Institute of Technology while screening for factors that protect neurons (PMID: 11717357). from Alzheimer's disease-related cell death. Like MOTS-c, it represents the MDP class — but with a distinctly different set of target pathways focused on cellular protection and cytosurvival.

Mechanism of Action

Humanin acts through multiple receptor systems including FPRL1 (formyl peptide receptor-like-1), the tripartite receptor complex CNTFR/WSX-1/gp130, and CXCR4. Its effects span several biological axes:

• •Anti-apoptotic signaling — direct inhibition of Bax-mediated programmed cell death, one of the primary mechanisms of neuronal loss in Alzheimer's disease
• •Neuroprotection — protection against amyloid-beta, IGFBP3, and other neurotoxic insults
• •Insulin sensitization — improved hepatic and peripheral insulin sensitivity through IGF-1/insulin pathway modulation
• •Cytoprotection — broad protection against ischemic, oxidative, and metabolic cellular stress
• •Reproductive longevity — Humanin levels correlate with ovarian reserve markers; declining Humanin tracks with reproductive aging

The longevity connection is supported by epidemiological data: in multiple studies of centenarian and super-centenarian populations, the offspring of long-lived individuals have significantly higher circulating Humanin levels than age-matched controls — suggesting Humanin may be both a mediator and biomarker of exceptional longevity.

Key Research

The discovery paper (Hashimoto Y et al., PNAS,, 2001) established Humanin's neuroprotective capacity against multiple familial Alzheimer's disease gene products. This launched extensive follow-up research across multiple disease models.

Subsequent work by the Cohens at USC documented:

• •Humanin's correlation with centenarian phenotypes in human population studies
• •Life extension in multiple animal models including C. elegans and rodents
• •Cardioprotective effects in ischemia-reperfusion injury
• •Preservation of cognitive function in aging rodent models

Particularly notable: Humanin knockout mice (lacking Humanin expression) show accelerated aging phenotypes, increased inflammation, and insulin resistance — establishing Humanin as a required component of normal aging physiology rather than merely a pharmacological intervention.

Research Status

Strong Preclinical + Epidemiological Evidence. Humanin has compelling mechanistic and epidemiological data supporting its longevity relevance. Direct administration studies in humans are limited; the evidence base is primarily preclinical with human epidemiological correlations.

Platform Pricing

Browse available Humanin products: /peptide/humanin. As a specialty MDP, pricing reflects limited production: typically $150–$350 per mg for research-grade material from validated suppliers.

Best Stacked With

Humanin + MOTS-c forms the core MDP longevity combination. Humanin + GHK-Cu is studied for broad cytoprotective and regenerative effects. Some researchers combine Humanin with SS-31 for a comprehensive mitochondrial health and cellular protection protocol.

---

5. SS-31 (Elamipretide)

Background

SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2), also known as Elamipretide or Bendavia (INN: Elamipretide), is an aromatic-cationic tetrapeptide developed by Hazel Szeto and Peter Schiller at Weill Cornell Medical College. It holds a unique position in this guide: it is the only compound that has advanced to Phase III clinical trials (in ischemic cardiomyopathy), giving it a substantially stronger human safety profile than all other peptides listed.

Mechanism of Action

SS-31's aromatic-cationic structure gives it a unique affinity for the inner mitochondrial membrane. Once localized there, it:

• •Binds cardiolipin — cardiolipin is a unique phospholipid found almost exclusively in the inner mitochondrial membrane that is essential for cristae architecture and electron transport chain (ETC) function. Cardiolipin content and proper acylation decline with age and in disease states.
• •Restores cristae morphology — mitochondria in aged cells show characteristic "cristae collapse" that impairs ETC complex assembly; SS-31 reverses this structural deterioration
• •Improves ATP synthesis — by restoring ETC complex interactions, SS-31 increases mitochondrial ATP production efficiency
• •Reduces mitochondrial ROS — antioxidant activity localized to the site of maximum free radical production (the inner mitochondrial membrane)
• •Prevents permeability transition pore (mPTP) opening — blocking this catastrophic mitochondrial event prevents unnecessary cell death in ischemia and other stress conditions

The mechanistic target — mitochondrial structural decay — is increasingly recognized as both a driver and consequence of biological aging. This positions SS-31 as a direct intervention against a fundamental aging mechanism rather than a downstream symptomatic target.

Key Research

Foundational work by Szeto et al. established SS-31's mitochondrial targeting mechanism and demonstrated cardiomyocyte protection from ischemia-reperfusion injury. This work also established SS-31's ability to reduce infarct size and preserve cardiac function in preclinical models.

For longevity applications specifically, groundbreaking research by Siegel et al. in aging mice demonstrated:

• •Old mice treated with SS-31 showed exercise capacity improvements equivalent to an 18-month (versus 27-month) mouse phenotype
• •Skeletal muscle mitochondrial function in SS-31-treated old mice was restored to near-youthful levels
• •The mechanism involved reversal of age-related cardiolipin loss and cristae remodeling

Multiple Phase II trials in heart failure patients established that SS-31 is well-tolerated at therapeutic doses over months of treatment, with no significant adverse events observed — providing uniquely robust human safety data for a longevity research compound.

Research Status

Advanced Clinical Development — Unique Among Longevity Peptides. SS-31's Phase II/III clinical experience places it in a different category of evidence than all other compounds in this guide. While the clinical indication was ischemic heart disease rather than longevity per se, the human pharmacokinetic and safety data is directly relevant to research planning.

Platform Pricing

Browse available SS-31 products: /peptide/ss-31. As a highly specialized research peptide, SS-31 commands premium pricing. Typical research quantities cost $200–$500 per mg from quality-documented suppliers.

Best Stacked With

SS-31's primary mechanistic role is mitochondrial structural restoration. SS-31 + MOTS-c provides complementary coverage — MOTS-c addressing mitochondrial metabolic signaling, SS-31 addressing structural integrity. This combination is of interest for researchers studying age-related mitochondrial bioenergetics comprehensively.

---

6. Thymalin (Thymus Bioregulator)

Background

Thymalin is a polypeptide preparation derived from bovine thymus tissue, developed as part of the Khavinson bioregulator program. It is classified as a tissue-specific bioregulator — a class of short peptides extracted from organs that act to restore the functional state of the corresponding tissue when administered systemically. Thymalin's target is the aging thymus gland and, by extension, the aging immune system.

The Thymus-Longevity Connection

The thymus gland is the primary training ground for T lymphocytes — the adaptive immune cells responsible for targeted pathogen elimination and tumor surveillance. Beginning in early adulthood, the thymus undergoes involution: progressive replacement of thymic parenchyma with adipose tissue. By age 65, most people have lost over 90% of their functional thymic tissue.

This progressive immunosenescence — aging of the immune system — has cascading consequences: increased susceptibility to infections, reduced vaccine efficacy, impaired tumor immune surveillance, and elevated chronic inflammation. Restoring even partial thymic function is therefore a potentially high-leverage longevity intervention.

Mechanism of Action

Thymalin research suggests it acts by:

• •Stimulating thymopoiesis — production and maturation of naïve T lymphocytes from bone marrow precursors
• •Restoring CD4:CD8 T cell ratios toward youthful patterns
• •Upregulating endogenous thymic peptide production (thymosin alpha-1, thymulin, thymopoietin)
• •Modulating cytokine balance — improving IL-2 and interferon-gamma while reducing age-associated pro-inflammatory IL-6 and TNF-alpha
• •Restoring NK cell cytotoxicity, which declines substantially with aging

Key Research

Khavinson and Morozov published multiple studies over several decades documenting Thymalin's immune-restoring effects in aging human subjects, including improvements in circulating T cell counts, NK cell activity, and immunoglobulin levels. Russian clinical research from the St. Petersburg Gerontological Center used Thymalin as part of an annual preventive protocol in aging populations.

The most remarkable finding from this research program is a six-year longitudinal study in which elderly subjects receiving annual Thymalin courses showed a 2.3-fold reduction in mortality compared to a control group — a striking result that, while methodologically limited by the standards of modern clinical trials, has fueled continued interest in thymic restoration as a longevity strategy.

Animal studies have consistently demonstrated increased lifespan, preserved immune function, reduced cancer incidence, and improved physical performance in Thymalin-treated aged rodents compared to controls.

Research Status

Preclinical + Russian Clinical Data. Thymalin has an unusually long clinical track record in Russian gerontology, though it lacks formal Western RCT validation. The mechanistic rationale for thymic restoration as a longevity intervention is sound and increasingly supported by Western research on thymus regeneration strategies.

Platform Pricing

Thymalin is available from several verified suppliers on the platform. Typical pricing ranges from $60 to $150 for a 10–20mg vial, with bulk pricing for multi-course research protocols.

Best Stacked With

Thymalin + Epithalon is the premier bioregulator combination, simultaneously targeting thymic-immune aging (Thymalin) and pineal-telomere biology (Epithalon). The Russian bioregulator research program has documented this combination in multiple studies. Some researchers add Vilon (a thymus-lymph bioregulator) for a more comprehensive immune-aging protocol.

---

7. BPC-157 (Body Protective Compound)

Background

BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice. Discovered and extensively characterized by Predrag Sikiric and colleagues at Zagreb University, it has accumulated one of the largest preclinical research bodies of any research peptide — with hundreds of published animal studies documenting effects across virtually every organ system.

In the longevity context, BPC-157 is most relevant as an anti-inflammaging compound — addressing the chronic, low-grade systemic inflammation that is now recognized as a primary driver of accelerated biological aging.

Mechanism of Action

BPC-157 interacts with multiple molecular targets:

• •VEGF pathway — potent stimulation of angiogenesis and vascular repair, essential for tissue perfusion and regenerative capacity
• •FAK-paxillin pathway — promotes cell survival, migration, and wound healing through focal adhesion kinase activation
• •Nitric oxide modulation — restoration of NO balance affecting vascular tone, neuroprotection, and gut motility
• •Gut-brain axis — modulation of dopaminergic, serotonergic, and GABAergic signaling through enteric nervous system effects
• •Intestinal barrier protection — reinforcement of tight junction integrity, preventing systemic endotoxemia from gut dysbiosis
• •Anti-inflammatory signaling — consistent reduction of TNF-alpha, IL-6, and COX-2 expression in inflammatory models

The gut barrier protection and systemic anti-inflammatory effects are particularly relevant to longevity, as intestinal permeability and chronic endotoxemia are increasingly recognized as drivers of inflammaging.

Key Research

Sikiric et al. have published extensively documenting BPC-157's tissue-healing effects. Key studies document accelerated healing of Achilles tendon transection, complete reversal of otherwise non-healing gastric ulcers, and protection against NSAID-induced gut damage in animal models.

For longevity-relevant outcomes, research has demonstrated:

• •Reversal of metabolic syndrome markers in high-fat diet rodent models
• •Preservation of dopaminergic signaling in aging brain models
• •Reduction of systemic inflammatory biomarkers consistent with inflammaging reversal
• •Protection against liver damage in alcohol, NSAID, and heavy metal toxicity models

BPC-157's consistent efficacy across diverse organ systems and injury types has led researchers to propose that it acts as a system-level modulator of tissue homeostasis rather than a simple wound-healing peptide — which would align it with broader longevity mechanisms.

Research Status

Strong Preclinical, No Human Trials. BPC-157 has an exceptionally robust preclinical evidence base but no formal Phase I/II clinical trials. Its research compound status limits the available human data, though its gastric-derived origin and animal safety profile are generally favorable.

Platform Pricing

BPC-157 is one of the most widely available research peptides on the platform. Pricing ranges from $25 to $100 for a 5mg vial, with substantial variation by supplier, purity certification, and form (lyophilized vs. pre-mixed solution).

Browse products: /peptide/bpc-157

Best Stacked With

BPC-157 + GHK-Cu is studied for synergistic connective tissue and skin regeneration. BPC-157 + TB-500 is the most widely studied tissue repair combination. For longevity applications, BPC-157 + Selank may address the gut-brain inflammation axis from complementary angles.

---

8. Selank

Background

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide analog of the endogenous immunopeptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. The added stabilizing amino acid sequence extends its plasma half-life beyond tuftsin's extremely short duration. It has been registered as a pharmaceutical drug in Russia and Ukraine for generalized anxiety disorder and neurasthenia.

In longevity research, Selank occupies a niche intersection of stress biology and immune-aging: chronic psychological stress is increasingly understood as an accelerator of biological aging through telomere shortening, inflammatory cytokine dysregulation, and HPA-axis-driven immunosuppression. Selank's capacity to modulate both stress biology and immune function makes it relevant to multi-factorial aging approaches.

Mechanism of Action

Selank's mechanisms span neurological and immunological systems:

• •GABA-A potentiation — anxiolytic effect through positive modulation of GABA-A receptors, without the dependence liability of benzodiazepines
• •Enkephalin metabolism regulation — inhibition of enkephalin-degrading enzymes, increasing endogenous opioid tone
• •BDNF upregulation — brain-derived neurotrophic factor expression increases in hippocampal and cortical tissue — relevant to age-related cognitive decline
• •IL-6 suppression — reduction of the chronically elevated pro-inflammatory IL-6 associated with aging and stress
• •T cell immune restoration — normalization of IL-2 and IFN-gamma in stress-suppressed immune models
• •Dopaminergic modulation — effects on dopamine metabolism in prefrontal cortical circuits

Key Research

Semenova et al. documented Selank's anxiolytic efficacy in rodent models alongside its immunomodulatory effects — specifically showing restoration of suppressed interferon production in stressed animals. Subsequent work characterized Selank's BDNF-upregulating effects in hippocampal tissue, placing it alongside compounds with neurotrophin-based cognitive protection mechanisms.

Clinical research in Russia documented Selank's efficacy in anxiety disorder patients with improvements in cognitive function, anxiety symptoms, and immune parameters (IL-2, IFN-gamma normalization) — providing some translational evidence for its dual neurological-immunological mechanism in humans.

Selank's registration as a pharmaceutical in Russia provides more human safety data than most other compounds in this guide.

Research Status

Preclinical + Human Safety Data (Russian Registration). Selank's pharmaceutical registration provides clinical safety documentation. Western clinical research is limited; mechanistic evidence is primarily preclinical.

Platform Pricing

Selank is available from multiple suppliers on the platform. Pricing ranges from $45 to $120 for a 5–10mg vial. Nasal spray formulations are offered by several suppliers at similar price points.

Browse products: /peptide/selank

Best Stacked With

Selank + Epithalon addresses both stress-immune aging and pineal-telomere biology. Selank + DSIP is studied for sleep quality and stress resilience. Selank + BPC-157 may target the gut-brain-immune axis from complementary angles.

---

Comparison Table: Top 8 Longevity Peptides at a Glance (2026)

---

Stacking Protocols for Longevity Research

Protocol 1: Telomere + Regeneration

Epithalon + GHK-Cu

The most classically studied combination in the longevity space. Epithalon addresses telomere length maintenance through telomerase activation and pineal-melatonin normalization, while GHK-Cu provides sweeping gene expression modulation toward tissue regeneration, autophagy, and antioxidant defense. Researchers studying cellular aging as a multi-dimensional phenotype frequently use this pairing as a foundation.

Protocol 2: Mitochondrial Comprehensive Stack

MOTS-c + Humanin + SS-31

Both MOTS-c and Humanin are mitochondria-derived peptides with distinct but complementary mechanisms. MOTS-c activates AMPK-mediated metabolic sensing; Humanin provides cytoprotective anti-apoptotic signaling. Adding SS-31 provides the structural component — cardiolipin stabilization and cristae morphology restoration. Together, these three compounds address mitochondrial metabolism, cytosurvival, and structural integrity simultaneously.

Protocol 3: Immune-Aging Restoration

Thymalin + Epithalon (+ Selank)

The Khavinson program's flagship combination, addressing thymic involution and immune aging (Thymalin) alongside pineal-melatonin aging (Epithalon). Adding Selank addresses the stress-immune axis — particularly relevant for subjects experiencing chronic psychological stress, which dramatically accelerates immune aging. This three-way combination represents the most comprehensive immune-longevity approach among bioregulator peptides.

---

How to Evaluate Longevity Peptide Suppliers

When sourcing longevity peptides for research, product quality is paramount — small structural variations or impurities can substantially alter biological activity and experimental validity.

Essential documentation to require:

• •Third-party HPLC purity certificate (target ≥98% for most compounds)
• •Mass spectrometry confirmation of molecular weight
• •Sterility and endotoxin testing for injectable research preparations
• •Certificate of Origin for the API (active pharmaceutical ingredient)

Platform verification: Peptides.SO's verified supplier badges indicate completion of our identity and documentation review process. Use the Supplier Directory to compare verified suppliers by product availability, pricing, and documentation standards.

Storage requirements: Lyophilized peptides require -20°C storage. Reconstituted peptides should be stored at 4°C and used within 4 weeks. Do not accept suppliers who cannot specify appropriate storage conditions.

---

Research Tools on Peptides.SO

• •Price Comparison — Side-by-side pricing across verified suppliers
• •Stack Builder — Design and analyze peptide research combinations
• •Dosage Calculator — Reconstitution and concentration math for research protocols
• •Supplier Directory — Verified supplier profiles with documentation status

---

Disclaimer

All compounds discussed in this guide are research peptides sold for laboratory and scientific investigation only. They are not FDA-approved for human use, not intended for self-administration or human consumption, and this content does not constitute medical advice. Regulatory status varies by jurisdiction; researchers are responsible for compliance with all applicable laws.

---

Conclusion

The 2026 longevity peptide research landscape offers mechanistically distinct tools covering the major known axes of biological aging — from telomere biology and mitochondrial dysfunction to thymic involution and chronic inflammaging. Whether your research interest is cellular aging mechanisms, systemic biomarker modulation, or translational healthspan interventions, the compounds reviewed here represent the current evidence-based frontier of longevity peptide science.

Use Peptides.SO's price comparison tools and supplier directory to source from verified, quality-documented suppliers — and the stack builder to design combination protocols grounded in the mechanistic rationale reviewed above.